These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23848176)

  • 41. A Randomized Trial of Oral Tranexamic Acid With Fluocinolone-Based Triple Cream Versus Fluocinolone Based Triple Cream Alone for the Treatment of Melasma.
    Perveen S; Rubin A; Berger L; Xiong W; Waqas N; Sharif S; Rao B
    J Drugs Dermatol; 2022 Mar; 21(3):321-322. PubMed ID: 35254752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women.
    Handog EB; Galang DA; de Leon-Godinez MA; Chan GP
    Int J Dermatol; 2009 Aug; 48(8):896-901. PubMed ID: 19659873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
    Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
    Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial.
    Rahmani B; Jahadi HR
    Ophthalmology; 1999 Feb; 106(2):375-9. PubMed ID: 9951493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic studies in women of 2 novel oral formulations of tranexamic acid therapy for heavy menstrual bleeding.
    Moore KA; Morin I; Marenco T; Lavigne JR; Morelli G
    Am J Ther; 2012 May; 19(3):190-8. PubMed ID: 21248612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prevention of postoperative bleeding in patients taking oral anticoagulants. Effects of tranexamic acid].
    Keiani Motlagh K; Loeb I; Legrand W; Daelemans P; Van Reck J
    Rev Stomatol Chir Maxillofac; 2003 Apr; 104(2):77-9. PubMed ID: 12750624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective, randomized, controlled trial of tranexamic acid in patients who undergo head and neck procedures.
    Chen CC; Wang CC; Wang CP; Lin TH; Lin WD; Liu SA
    Otolaryngol Head Neck Surg; 2008 Jun; 138(6):762-7. PubMed ID: 18503851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell disease.
    Davis NF; McGuire BB; Lawlor L; O'Gorman P; O'Malley KJ; Fitzpatrick JM
    Ann Hematol; 2010 Nov; 89(11):1179-80. PubMed ID: 20358201
    [No Abstract]   [Full Text] [Related]  

  • 49. Dynamic Optical Coherence Tomography of Cutaneous Blood Vessels in Melasma and Vessel Response to Oral Tranexamic Acid.
    Pomerantz H; Christman MP; Bloom BS; Lederhandler M; Feng H; Holmes J; Geronemus RG
    Lasers Surg Med; 2021 Aug; 53(6):861-864. PubMed ID: 33161588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of idiopathic menorrhagia with tranexamic acid.
    Srinil S; Jaisamrarn U
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S1-6. PubMed ID: 17722310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Use of Tranexamic Acid to Prevent and Treat Post-Inflammatory Hyperpigmentation.
    Lindgren AL; Austin AH; Welsh KM
    J Drugs Dermatol; 2021 Mar; 20(3):344-345. PubMed ID: 33683077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 1927nm Fractional Diode Laser and Oral Tranexamic Acid for Melasma: A 5.7-Year Summary on Safety and Effectiveness.
    Wang JV; Valiga A; Geronemus RG
    Dermatol Surg; 2022 Aug; 48(8):883-885. PubMed ID: 35580252
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy of tranexamic acid in sporadic idiopathic bradykinin angioedema.
    Du-Thanh A; Raison-Peyron N; Drouet C; Guillot B
    Allergy; 2010 Jun; 65(6):793-5. PubMed ID: 19886924
    [No Abstract]   [Full Text] [Related]  

  • 54. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypopigmentation as a side effect of melasma treatment with tranexamic acid intradermal microinjections.
    Litaiem N; Daadaa N; Karray M; Chamli A; Zeglaoui F
    Dermatol Ther; 2020 Jul; 33(4):e13503. PubMed ID: 32358856
    [No Abstract]   [Full Text] [Related]  

  • 56. A preliminary study of a new tranexamic acid dosing schedule for cardiac surgery.
    Nuttall GA; Gutierrez MC; Dewey JD; Johnson ME; Oyen LJ; Hanson AC; Oliver WC
    J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):230-5. PubMed ID: 18375325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of hydroporation on melasma with anti-aging cocktail.
    Chae JB; Yang SH; Byun SY; Choi HR; Shin JW; Park KC
    J Cosmet Dermatol; 2017 Dec; 16(4):e15-e20. PubMed ID: 28133891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of oral therapy for the prevention of postinflammatory hyperpigmentation.
    McDaniel DH
    Dermatol Surg; 2011 May; 37(5):611. PubMed ID: 21518099
    [No Abstract]   [Full Text] [Related]  

  • 59. Topical use of tranexamic acid to control perioperative local bleeding in gynaecology patients with clotting disorders: two cases.
    Sarris I; Arafa A; Konaris L; Kadir RA
    Haemophilia; 2007 Jan; 13(1):115-6. PubMed ID: 17212738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of tranexamic acid mouthwash to prevent postoperative bleeding in oral surgery patients on oral anticoagulant medication.
    Gaspar R; Brenner B; Ardekian L; Peled M; Laufer D
    Quintessence Int; 1997 Jun; 28(6):375-9. PubMed ID: 9477900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.